top of page
  • CCS

Extension of Tax Incentive for Pharmaceutical Companies

Updated: Nov 9, 2022

To Download Budget 2023 Speech and some other related publications -

Current Position

To attract investment in Malaysia on the part of makers of pharmaceutical products, including vaccines, in particular, the COVID-19 vaccine, Manufacturer of pharmaceutical products is eligible for tax incentive as follows::

  • income tax rate of 0% up to 10%for the first 10 years; and

  • income tax rate of 10% for the subsequent 10 years.

The tax incentives will be effective for applications received by the Malaysian Investment and Development Authority from November 7, 2020, to December 31, 2022.


To further encourage the development and manufacturing of pharmaceutical products, particularly vaccines, the proposed tax incentive is extended for 3 years.

Effective Date

For applications received by MIDA from January 1, 2023, until December 31. 2025.

Our website's articles, templates, and material are solely for reference. Although we make every effort to keep the information up to date and accurate, we make no representations or warranties of any kind, either express or implied, regarding the website or the information, articles, templates, or related graphics that are contained on the website in terms of its completeness, accuracy, reliability, suitability, or availability. Therefore, any reliance on such information is strictly at your own risk.

Keep in touch with us so that you can receive timely updates |


1. Website ✍️ 2. Telegram ✍️ 3. Facebook ✍

4. Blog ✍ 5. Google ✍

6. LinkedIn ✍

103 views0 comments

Recent Posts

See All
bottom of page